Moxiforce 375 Jun 2026

Clavulanic acid systematically seeks out and deactivates defensive bacterial proteins.

Moxiforce 375 is prescribed for the treatment of susceptible bacterial strains causing: moxiforce 375

Each therapeutic film-coated tablet of Moxiforce CV 375 features a fixed-dose combination: 250 mg Clavulanic Acid (as Potassium Clavulanate USP/BP): 125 mg Understanding the Formulation Math moxiforce 375

contains Moxifloxacin (375 mg) , a fourth-generation fluoroquinolone antibiotic. It is designed to combat a wide range of gram-positive and gram-negative bacteria by inhibiting bacterial DNA replication. This once-daily formulation offers potent bactericidal action against complex respiratory and skin infections. moxiforce 375